BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20525894)

  • 21. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.
    Godschalk PC; Heikema AP; Gilbert M; Komagamine T; Ang CW; Glerum J; Brochu D; Li J; Yuki N; Jacobs BC; van Belkum A; Endtz HP
    J Clin Invest; 2004 Dec; 114(11):1659-65. PubMed ID: 15578098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
    Geleijns K; Jacobs BC; Van Rijs W; Tio-Gillen AP; Laman JD; van Doorn PA
    J Neuroimmunol; 2004 May; 150(1-2):132-8. PubMed ID: 15081257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipooligosaccharide of Campylobacter jejuni prevents myelin-specific enteral tolerance to autoimmune neuritis--a potential mechanism in Guillain-Barre syndrome?
    Jung S; Zimmer S; Lüneberg E; Frosch M; Karch H; Korn T; Toyka KV
    Neurosci Lett; 2005 Jun 10-17; 381(1-2):175-8. PubMed ID: 15882812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
    Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
    Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion.
    Louwen R; Heikema A; van Belkum A; Ott A; Gilbert M; Ang W; Endtz HP; Bergman MP; Nieuwenhuis EE
    Infect Immun; 2008 Oct; 76(10):4431-8. PubMed ID: 18644887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome.
    Godschalk PC; van Belkum A; van den Braak N; van Netten D; Ang CW; Jacobs BC; Gilbert M; Endtz HP
    J Clin Microbiol; 2007 Jul; 45(7):2316-20. PubMed ID: 17507514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
    Yuki N
    Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial infections in Guillain-Barré and Fisher syndromes.
    Yuki N; Koga M
    Curr Opin Neurol; 2006 Oct; 19(5):451-7. PubMed ID: 16969154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Origin of ganglioside complex antibodies in Guillain-Barré syndrome.
    Kuijf ML; Godschalk PC; Gilbert M; Endtz HP; Tio-Gillen AP; Ang CW; van Doorn PA; Jacobs BC
    J Neuroimmunol; 2007 Aug; 188(1-2):69-73. PubMed ID: 17604126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass spectrometric analysis of intact lipooligosaccharide: direct evidence for O-acetylated sialic acids and discovery of O-linked glycine expressed by Campylobacter jejuni.
    Dzieciatkowska M; Brochu D; van Belkum A; Heikema AP; Yuki N; Houliston RS; Richards JC; Gilbert M; Li J
    Biochemistry; 2007 Dec; 46(50):14704-14. PubMed ID: 18034462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity.
    Moran AP; Prendergast MM
    J Autoimmun; 2001 May; 16(3):241-56. PubMed ID: 11334489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axonal degeneration induced by intraneural injection of Campylobacter jejuni antiserum containing high titer anti-GM1 antibody.
    Shu XM; Cai FC; Zhang XP
    Neuropediatrics; 2007 Oct; 38(5):228-32. PubMed ID: 18330836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR4 promotes B cell maturation: independence and cooperation with B lymphocyte-activating factor.
    Hayashi EA; Granato A; Paiva LS; Bertho AL; Bellio M; Nobrega A
    J Immunol; 2010 May; 184(9):4662-72. PubMed ID: 20357250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.
    Bowes T; Wagner ER; Boffey J; Nicholl D; Cochrane L; Benboubetra M; Conner J; Furukawa K; Furukawa K; Willison HJ
    Infect Immun; 2002 Sep; 70(9):5008-18. PubMed ID: 12183547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome.
    Hye JB; Nachamkin I
    Neurology; 2007 May; 68(19):1633-4. PubMed ID: 17485654
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.
    Caporale CM; Capasso M; Luciani M; Prencipe V; Creati B; Gandolfi P; De Angelis MV; Di Muzio A; Caporale V; Uncini A
    J Neuroimmunol; 2006 May; 174(1-2):12-20. PubMed ID: 16516981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.